• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开放性根治性肾切除术在当代肾细胞癌治疗中的作用。

The role of open radical nephrectomy in contemporary management of renal cell carcinoma.

作者信息

Kalapara Arveen A, Frydenberg Mark

机构信息

Department of Surgery, Monash University, Melbourne, Australia.

Cabrini Institute, Cabrini Health, Melbourne, Australia.

出版信息

Transl Androl Urol. 2020 Dec;9(6):3123-3139. doi: 10.21037/tau-19-327.

DOI:10.21037/tau-19-327
PMID:33457285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807349/
Abstract

Radical nephrectomy (RN) remains a cornerstone of the management of localised renal cell carcinoma (RCC). RN involves the en bloc removal of the kidney along with perinephric fat enclosed within Gerota's fascia. Key principles of open RN include appropriate incision for adequate exposure, dissection and visualisation of the renal hilum, and early ligation of the renal artery and subsequently renal vein. Regional lymph node dissection (LND) facilitates local staging but its therapeutic role remains controversial. LND is recommended in patients with high risk clinically localised disease, but its benefit in low risk node-negative and clinically node-positive patients is unclear. Concomitant adrenalectomy should be reserved for patients with large tumours with radiographic evidence of adrenal involvement. Despite a recent downtrend in utilisation of open RN due to nephron-sparing and minimally invasive alternatives, there remains a vital role for open RN in the management of RCC in three domains. Firstly, open RN is important to the management of large, complex tumours which would be at high risk of complications if treated with partial nephrectomy (PN). Secondly, open RN plays a crucial role in cytoreductive nephrectomy (CN) for metastatic RCC, in which the laparoscopic approach achieves similar results but is associated with a high reoperation rate. Finally, open RN is the current standard of care in the management of inferior vena caval (IVC) tumour thrombus. Management of tumour thrombus requires a multidisciplinary approach and varies with cranial extent of thrombus. Higher level thrombus may require hepatic mobilisation and circulatory support, whilst the presence of bland thrombus may warrant post-operative filter insertion or ligation of the IVC.

摘要

根治性肾切除术(RN)仍然是局限性肾细胞癌(RCC)治疗的基石。RN包括整块切除肾脏以及肾周筋膜内的肾周脂肪。开放性RN的关键原则包括进行适当的切口以获得充分暴露、解剖和观察肾门,并早期结扎肾动脉,随后结扎肾静脉。区域淋巴结清扫术(LND)有助于局部分期,但其治疗作用仍存在争议。对于临床局限性高危疾病患者建议进行LND,但对于低风险淋巴结阴性和临床淋巴结阳性患者其益处尚不清楚。对于有影像学证据显示肾上腺受累的大肿瘤患者应保留肾上腺切除术。尽管由于保留肾单位和微创替代方案,开放性RN的应用最近呈下降趋势,但开放性RN在RCC治疗的三个领域中仍起着至关重要的作用。首先,开放性RN对于大的复杂肿瘤的治疗很重要,如果采用部分肾切除术(PN)治疗,这些肿瘤会有很高的并发症风险。其次,开放性RN在转移性RCC的减瘤性肾切除术(CN)中起着关键作用,在这种手术中,腹腔镜手术方法可取得类似结果,但再手术率较高。最后,开放性RN是目前治疗下腔静脉(IVC)肿瘤血栓的标准治疗方法。肿瘤血栓的治疗需要多学科方法,并且随血栓的头端范围而有所不同。较高水平的血栓可能需要肝脏游离和循环支持,而存在非感染性血栓可能需要术后置入滤网或结扎IVC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/b84a646bc558/tau-09-06-3123-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/a71f73f8f177/tau-09-06-3123-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/d83cfc7ec6bd/tau-09-06-3123-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/b84a646bc558/tau-09-06-3123-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/a71f73f8f177/tau-09-06-3123-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/d83cfc7ec6bd/tau-09-06-3123-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd1/7807349/b84a646bc558/tau-09-06-3123-f3.jpg

相似文献

1
The role of open radical nephrectomy in contemporary management of renal cell carcinoma.开放性根治性肾切除术在当代肾细胞癌治疗中的作用。
Transl Androl Urol. 2020 Dec;9(6):3123-3139. doi: 10.21037/tau-19-327.
2
Minimally invasive radical nephrectomy: a contemporary review.微创根治性肾切除术:当代综述
Transl Androl Urol. 2020 Dec;9(6):3112-3122. doi: 10.21037/tau-2019-suc-16.
3
Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.肾细胞癌中肿瘤栓子与无病变血栓的关系:分析手术意义及下腔静脉阻断的作用。
BJU Int. 2012 Dec;110(11 Pt B):E449-55. doi: 10.1111/j.1464-410X.2012.11128.x. Epub 2012 Apr 30.
4
Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.肾细胞癌(RCC)合并下腔静脉(IVC)瘤栓的重要手术考虑因素。
BJU Int. 2012 Oct;110(7):926-39. doi: 10.1111/j.1464-410X.2012.11174.x. Epub 2012 Apr 30.
5
Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical steps.腹腔镜下根治性肾切除术联合下腔静脉血栓切除术:关键手术步骤要点
Int Braz J Urol. 2016 Jul-Aug;42(4):856-7. doi: 10.1590/S1677-5538.IBJU.2015.0080.
6
Laparoscopic Radical Nephrectomy and Inferior Vena Cava Thrombectomy in the Treatment of Renal Cell Carcinoma.腹腔镜根治性肾切除术和下腔静脉取栓术治疗肾细胞癌。
Eur Urol. 2015 Jul;68(1):115-22. doi: 10.1016/j.eururo.2014.12.011. Epub 2014 Dec 19.
7
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium.体外循环和深低温停循环下肾细胞癌侵犯膈上下腔静脉和/或右心房行肾切除术和腔静脉血栓切除术的围手术期和肿瘤学结果。
Eur Urol. 2018 May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13.
8
European temporal trends in the use of lymph node dissection in patients with renal cancer.欧洲肾癌患者淋巴结清扫术使用情况的时间趋势
Eur J Surg Oncol. 2017 Nov;43(11):2184-2192. doi: 10.1016/j.ejso.2017.07.016. Epub 2017 Aug 3.
9
Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results.腹腔镜辅助肾切除术联合下腔静脉肿瘤血栓切除术:初步结果
Urology. 2004 Nov;64(5):925-9. doi: 10.1016/j.urology.2004.05.044.
10
Open surgery for localized RCC.局限性肾细胞癌的开放手术
ScientificWorldJournal. 2007 Jan 22;7:742-52. doi: 10.1100/tsw.2007.142.

引用本文的文献

1
A Novel Hybrid Surgical Technique for Large Renal Masses-Hybrid Technique of Laparoscopic-Assisted Open Radical Nephrectomy.一种用于大型肾肿物的新型混合手术技术——腹腔镜辅助开放性根治性肾切除术的混合技术
Urol Res Pract. 2025 Jul 29;51(4):131-135. doi: 10.5152/tud.2025.24090.
2
Risk Factors Associated With Unplanned Conversion to Open in Radical and Partial Nephrectomy.根治性肾切除术和部分肾切除术中计划外转为开放手术的相关危险因素。
Cureus. 2025 Jun 1;17(6):e85168. doi: 10.7759/cureus.85168. eCollection 2025 Jun.
3
Surgical Management of Renal Cell Carcinoma in Transplanted Kidneys-A Narrative Review.

本文引用的文献

1
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.美国肾细胞癌的临床分期迁移和生存情况。
Eur Urol Oncol. 2019 Jul;2(4):343-348. doi: 10.1016/j.euo.2018.08.023. Epub 2018 Sep 25.
2
Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019.2019年转移性肾细胞癌减瘤性肾切除术作用的重新评估
Am Soc Clin Oncol Educ Book. 2019 Jan;39:276-283. doi: 10.1200/EDBK_237453. Epub 2019 May 17.
3
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.
移植肾肾细胞癌的外科治疗——一项叙述性综述
Cancers (Basel). 2025 May 31;17(11):1864. doi: 10.3390/cancers17111864.
4
Renal cell carcinoma and upper tract urothelial carcinoma in kidney transplant recipients.肾移植受者中的肾细胞癌和上尿路尿路上皮癌
J Med Life. 2025 Apr;18(4):357-363. doi: 10.25122/jml-2025-0065.
5
Incidence of Proteinuria Post Radical Nephrectomy in Comparison to Partial Nephrectomy: A Comparative Study.根治性肾切除术后与部分肾切除术后蛋白尿的发生率:一项比较研究。
Cureus. 2024 Dec 28;16(12):e76548. doi: 10.7759/cureus.76548. eCollection 2024 Dec.
6
Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombus.术前全身治疗对伴有下腔静脉瘤栓的肾细胞癌围手术期结局的影响
Int J Clin Oncol. 2025 Mar;30(3):532-538. doi: 10.1007/s10147-024-02680-3. Epub 2024 Dec 12.
7
Outcome of delayed presentation in patients with giant renal cell carcinoma: A case report.巨大肾细胞癌患者延迟就诊的结局:一例报告
Int J Surg Case Rep. 2024 Dec;125:110541. doi: 10.1016/j.ijscr.2024.110541. Epub 2024 Oct 29.
8
Potential Nephroprotective Effect of Kaempferol: Biosynthesis, Mechanisms of Action, and Clinical Prospects.山奈酚的潜在肾保护作用:生物合成、作用机制及临床前景
Adv Pharmacol Pharm Sci. 2024 Sep 30;2024:8907717. doi: 10.1155/2024/8907717. eCollection 2024.
9
[Not Available].[无可用内容]
CMAJ. 2024 May 5;196(17):E601-E607. doi: 10.1503/cmaj.230356-f.
10
Advances in the management of renal cell carcinoma.肾细胞癌管理方面的进展
CMAJ. 2024 Feb 25;196(7):E235-E240. doi: 10.1503/cmaj.230356.
舒尼替尼治疗同步转移性肾细胞癌患者中即刻与延迟细胞减瘤性肾切除术的比较:SURTIME 随机临床试验。
JAMA Oncol. 2019 Feb 1;5(2):164-170. doi: 10.1001/jamaoncol.2018.5543.
4
Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.预测部分肾切除术和根治性肾切除术的肾功能结果。
Eur Urol. 2019 May;75(5):766-772. doi: 10.1016/j.eururo.2018.11.021. Epub 2018 Nov 23.
5
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.系统评价细胞减积性肾切除术在靶向治疗时代及以后的作用:转移性肾细胞癌的个体化治疗方法。
Eur Urol. 2019 Jan;75(1):111-128. doi: 10.1016/j.eururo.2018.09.016. Epub 2018 Oct 25.
6
Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy.晚期肾癌的外科治疗:减瘤性肾切除术和淋巴结清扫术的作用
J Clin Oncol. 2018 Oct 29:JCO2018790246. doi: 10.1200/JCO.2018.79.0246.
7
Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.根治性肾切除术与部分肾切除术治疗 cT1 期肾癌。
Eur Urol. 2018 Dec;74(6):825-832. doi: 10.1016/j.eururo.2018.08.028. Epub 2018 Sep 24.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.肾小球滤过率的每一个单位都有安全下限:评估肾功能与肾细胞癌特异性死亡率之间的关系。
Eur Urol. 2018 Nov;74(5):661-667. doi: 10.1016/j.eururo.2018.07.029. Epub 2018 Aug 10.
10
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.基于肾肿瘤大小的侵袭性与惰性组织学概率:对监测和治疗的影响。
Eur Urol. 2018 Oct;74(4):489-497. doi: 10.1016/j.eururo.2018.06.003. Epub 2018 Jul 13.